Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The 40-week trial tested three doses of orforglipron3 milligrams, 12 milligrams, and 36 milligramsagainst a placebo in 559 patients with type 2 diabetes
If you feel any pressure, stop, and allow the syringe to adjust
Rules for the sale, supply and administration of medicines for specific healthcare professionals GOV.UK
Updated Valuation Viking Therapeutics currently has 18 Wall Street analysts covering the stock with an average price target of $92.72, a 204% increase from todays price at $30.45 (end of trading 17/02/26)
Hearn EB et al
US$ 29.53
US$ 29.76
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 28.39
US$ 28.81
US$ 28.28
